EMA Withdrawn: Viracept (nelfinavir) — Roche Registration Ltd.

View source ↗

Summary

Viracept (nelfinavir) has been withdrawn from the European market by Roche Registration Ltd., with the decision dated 23 January 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Viracept (Nelfinavir)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Roche Registration Ltd.. Decision date: 23/01/2013